Epilim Intravenous (Sodium Valproate)

Epilim Intravenous is a medication containing Sodium Valproate, used for various therapeutic purposes. It is administered intravenously and is manufactured by Sanofi-Aventis Ireland Ltd. T/A Sanofi.

Epilim Intravenous is primarily used for the management of certain types of seizures and as a mood stabilizer. It is often prescribed for conditions where oral administration is not feasible or practical. The medication works by affecting the central nervous system to help control abnormal brain activity.

Common effects of Epilim Intravenous may include drowsiness, dizziness, and gastrointestinal discomfort. Some users may experience changes in appetite or weight. It is important to monitor for any unusual symptoms and consult a healthcare provider if they persist or worsen.

Epilim Intravenous should be handled with care and administered under medical supervision. It is important to inform healthcare providers about any allergies or other medications being taken. Pregnant women or those planning to become pregnant should discuss the risks and benefits with their healthcare provider.

Epilim Intravenous may interact with other medications, including those that affect the central nervous system or blood clotting. It is important to avoid alcohol while using this medication, as it can increase the risk of side effects. Always consult a healthcare provider before starting or stopping any medication.